Participate in a trial for painful diabetic neuropathy

The longer you have diabetes and the older you are, the greater the chances are that you may develop painful diabetic neuropathy in your feet or legs. If you are living with this condition and have not found adequate pain relief, you may be eligible to participate in the SENZA-PDN clinical trial.

About the SENZA-PDN trial

This trial is comparing HF10®, a medical-device-based therapy, in combination with standard medical treatment1 to standard medical treatment alone in people who have painful diabetic neuropathy (also known as diabetic nerve pain). Eligible participants will receive study-related treatment at no cost and may receive compensation for time and travel. Learn more about the SENZA-PDN trial.

How HF10® works

HF10® includes the use of mild electrical pulses delivered near the spine that quiet the nerves that send chronic pain signals to the brain. This device has been approved by the US FDA for the treatment of back and leg pain and shown to provide significant relief.2 This study will evaluate HF10® as a potential treatment option for diabetic neuropathy pain.

1 Standard medical treatment includes the use of medication, physical therapy, cognitive therapy, chiropractic care, nerve blocks and other noninvasive or minimally invasive therapies.
2 Kapural L. et al. Novel 10-kHz high-frequency therapy (HF10 Therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain. Anesthesiology, 123(4).

See if you qualify